Works by Mahalingam, Devalingam

Results: 47

Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial.

Published in:

Clinical Lung Cancer, 2025, v. 26, n. 3, p. 191, doi. 10.1016/j.cllc.2024.12.003

By:

Goldman, Jonathan W.;
Bueno, Alejandro Martinez;
Dooms, Christophe;
Jhaveri, Komal;
de Miguel, Maria;
Piha-Paul, Sarina A.;
Unni, Nisha;
Zick, Aviad;
Mahipal, Amit;
Suga, J. Marie;
Naltet, Charles;
Antoñanzas, Monica;
Crown, John;
Bebchuk, Judith;
Eli, Lisa D.;
Lowenthal, Beth H.;
Mahalingam, Devalingam

Publication type:

Article

Clinical activity of mammalian target of rapamycin inhibitors in solid tumors.

Published in:

2011

By:

Alvarado, Yesid;
Mita, Monica;
Vemulapalli, Sushma;
Mahalingam, Devalingam;
Mita, Alain;
Mita, Monica M;
Mita, Alain C

Publication type:

journal article

Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.

Published in:

2009

By:

Kelly, Kevin;
Swords, Ronan;
Mahalingam, Devalingam;
Padmanabhan, Swaminathan;
Giles, Francis;
Giles, Francis J

Publication type:

journal article

The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents.

Published in:

2009

By:

Sankhala, Kamalesh;
Mita, Alain;
Kelly, Kevin;
Mahalingam, Devalingam;
Giles, Francis;
Mita, Monica

Publication type:

journal article

The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1518-0

By:

Mahalingam, Devalingam;
Patel, Sukeshi;
Nuovo, Gerard;
Gill, George;
Selvaggi, Giovanni;
Coffey, Matt;
Nawrocki, Steffan T.

Publication type:

Article

The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer.

Published in:

2015

By:

Mahalingam, Devalingam;
Patel, Sukeshi;
Nuovo, Gerard;
Gill, George;
Selvaggi, Giovanni;
Coffey, Matt;
Nawrocki, Steffan T

Publication type:

journal article

Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx ): a placebo-controlled randomised phase II study (PLIANT).

Published in:

Acta Oncologica, 2018, v. 57, n. 3, p. 393, doi. 10.1080/0284186X.2017.1398836

By:

Glimelius, Bengt;
Manojlovic, Nebojsa;
Pfeiffer, Per;
Mosidze, Baadur;
Kurteva, Galina;
Karlberg, Mia;
Mahalingam, Devalingam;
Jensen, Peter Buhl;
Kowalski, Jan;
Bengtson, Marie;
Nittve, Malin;
Näsström, Jacques

Publication type:

Article

Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).

Published in:

JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1439, doi. 10.1093/jnci/djae098

By:

Fontana, Elisa;
Rosen, Ezra;
Lee, Elizabeth K;
Højgaard, Martin;
Mettu, Niharika B;
Lheureux, Stephanie;
Carneiro, Benedito A;
Cote, Gregory M;
Carter, Louise;
Plummer, Ruth;
Mahalingam, Devalingam;
Fretland, Adrian J;
Schonhoft, Joseph D;
Silverman, Ian M;
Wainszelbaum, Marisa;
Xu, Yi;
Ulanet, Danielle;
Koehler, Maria;
Yap, Timothy A

Publication type:

Article

A phase II study of REOLYSIN<sup>®</sup> (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma.

Published in:

2017

By:

Mahalingam, Devalingam;
Fountzilas, Christos;
Moseley, Jennifer;
Noronha, Nicole;
Tran, Hue;
Chakrabarty, Romit;
Selvaggi, Giovanni;
Coffey, Matthew;
Thompson, Brad;
Sarantopoulos, John

Publication type:

journal article

Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1241, doi. 10.1007/s00280-014-2602-x

By:

Mahalingam, Devalingam;
Nemunaitis, John;
Malik, Laeeq;
Sarantopoulos, John;
Weitman, Steven;
Sankhala, Kamalesh;
Hart, Jessica;
Kousba, Ahmed;
Gallegos, Nicole;
Anderson, Gavin;
Charles, John;
Rogers, Jon;
Senzer, Neil;
Mita, Alain

Publication type:

Article

Predicting success in regulatory approval from Phase I results.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1099, doi. 10.1007/s00280-014-2596-4

By:

Malik, Laeeq;
Mejia, Alex;
Parsons, Helen;
Ehler, Benjamin;
Mahalingam, Devalingam;
Brenner, Andrew;
Sarantopoulos, John;
Weitman, Steven

Publication type:

Article

Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 77, doi. 10.1007/s00280-014-2479-8

By:

Mahalingam, Devalingam;
Malik, Laeeq;
Beeram, Muralidhar;
Rodon, Jordi;
Sankhala, Kamalesh;
Mita, Alain;
Benjamin, Daniel;
Ketchum, Norma;
Michalek, Joel;
Tolcher, Anthony;
Wright, John;
Sarantopoulos, John

Publication type:

Article

Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal Cancer.

Published in:

Tomography: A Journal for Imaging Research, 2025, v. 11, n. 3, p. 20, doi. 10.3390/tomography11030020

By:

Gennaro, Nicolò;
Soliman, Moataz;
Borhani, Amir A.;
Kelahan, Linda;
Savas, Hatice;
Avery, Ryan;
Subedi, Kamal;
Trabzonlu, Tugce A.;
Krumpelman, Chase;
Yaghmai, Vahid;
Chae, Young;
Lorch, Jochen;
Mahalingam, Devalingam;
Mulcahy, Mary;
Benson, Al;
Bagci, Ulas;
Velichko, Yuri S.

Publication type:

Article

Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 13, p. 5098, doi. 10.1245/s10434-020-08938-0

By:

Brajcich, Brian C.;
Bentrem, David J.;
Yang, Anthony D.;
Cohen, Mark E.;
Ellis, Ryan J.;
Mahalingam, Devalingam;
Mulcahy, Mary F.;
Lidsky, Michael E.;
Allen, Peter J.;
Merkow, Ryan P.

Publication type:

Article

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib.

Published in:

Journal of Cellular & Molecular Medicine, 2011, v. 15, n. 10, p. 2057, doi. 10.1111/j.1582-4934.2010.01218.x

By:

Kelly, Kevin R.;
Ecsedy, Jeffrey;
Medina, Ernest;
Mahalingam, Devalingam;
Padmanabhan, Swaminathan;
Nawrocki, Steffan T.;
Giles, Francis J.;
Carew, Jennifer S.

Publication type:

Article

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.

Published in:

Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 10, p. 2448, doi. 10.1111/j.1582-4934.2009.00832.x

By:

Carew, Jennifer S.;
Medina, Ernest C.;
Esquivel II, Juan A.;
Mahalingam, Devalingam;
Swords, Ronan;
Kelly, Kevin;
Zhang, Hui;
Huang, Peng;
Mita, Alain C.;
Mita, Monica M.;
Giles, Francis J.;
Nawrocki, Steffan T.

Publication type:

Article

Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors.

Published in:

Drugs in R&D, 2016, v. 16, n. 1, p. 45, doi. 10.1007/s40268-015-0114-8

By:

Falchook, Gerald;
Zhou, Xiaofei;
Venkatakrishnan, Karthik;
Kurzrock, Razelle;
Mahalingam, Devalingam;
Goldman, Jonathan;
Jung, JungAh;
Ullmann, Claudio;
Milch, Catherine;
Rosen, Lee;
Sarantopoulos, John

Publication type:

Article

Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma.

Published in:

Cancers, 2025, v. 17, n. 5, p. 715, doi. 10.3390/cancers17050715

By:

Demir, Tarik;
Moloney, Carolyn;
Mahalingam, Devalingam

Publication type:

Article

Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test.

Published in:

Cancers, 2021, v. 13, n. 13, p. 3109, doi. 10.3390/cancers13133109

By:

Mahalingam, Devalingam;
Chelis, Leonidas;
Nizamuddin, Imran;
Lee, Sunyoung S.;
Kakolyris, Stylianos;
Halff, Glenn;
Washburn, Ken;
Attwood, Kristopher;
Fahad, Ibnshamsah;
Grigorieva, Julia;
Asmellash, Senait;
Meyer, Krista;
Oliveira, Carlos;
Roder, Heinrich;
Roder, Joanna;
Iyer, Renuka

Publication type:

Article

The Landscape of Targeted Therapies in TNBC.

Published in:

Cancers, 2020, v. 12, n. 4, p. 916, doi. 10.3390/cancers12040916

By:

Vagia, Elena;
Mahalingam, Devalingam;
Cristofanilli, Massimo

Publication type:

Article

Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC).

Published in:

Cancers, 2019, v. 11, n. 8, p. 1085, doi. 10.3390/cancers11081085

By:

Viveiros, Pedro;
Riaz, Ahsun;
Lewandowski, Robert J.;
Mahalingam, Devalingam

Publication type:

Article

Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models.

Published in:

Cancers, 2019, v. 11, n. 7, p. 895, doi. 10.3390/cancers11070895

By:

Mahalingam, Devalingam;
Carew, Jennifer S.;
Espitia, Claudia M.;
Cool, Robbert H.;
Giles, Francis J.;
de Jong, Steven;
Nawrocki, Steffan T.

Publication type:

Article

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization.

Published in:

Cancers, 2019, v. 11, n. 6, p. 879, doi. 10.3390/cancers11060879

By:

Antkowiak, Mark;
Gabr, Ahmed;
Das, Arighno;
Ali, Rehan;
Kulik, Laura;
Ganger, Daniel;
Moore, Christopher;
Abecassis, Michael;
Katariya, Nitin;
Mouli, Samdeep;
Mahalingam, Devalingam;
Lewandowski, Robert J.;
Salem, Riad;
Riaz, Ahsun

Publication type:

Article

A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma.

Published in:

Cancers, 2019, v. 11, n. 6, p. 833, doi. 10.3390/cancers11060833

By:

Mahalingam, Devalingam;
Peguero, Julio;
Cen, Putao;
Arora, Sukeshi P.;
Sarantopoulos, John;
Rowe, Julie;
Allgood, Victoria;
Tubb, Benjamin;
Campos, Luis

Publication type:

Article

A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.

Published in:

Cancers, 2018, v. 10, n. 6, p. 160, doi. 10.3390/cancers10060160

By:

Mahalingam, Devalingam;
Goel, Sanjay;
Aparo, Santiago;
Patel Arora, Sukeshi;
Noronha, Nicole;
Tran, Hue;
Chakrabarty, Romit;
Selvaggi, Giovanni;
Gutierrez, Andres;
Coffey, Matthew;
Nawrocki, Steffan T.;
Nuovo, Gerard;
Mita, Monica M.

Publication type:

Article

A trial of radiolabeled antibody yttrium‐90–FF‐21101 for the treatment of advanced ovarian and other cancers.

Published in:

Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35680

By:

Mahalingam, Devalingam;
Owonikoko, Taofeek K.;
Delpassand, Ebrahim;
Mulcahy, Mary F.;
Kalyan, Aparna;
Ulahannan, Susanna;
Cheung, Kin;
Izumi, Yasayuki;
Johansen, Mary;
Madden, Timothy;
Shimoyama, Susumu;
Subach, Ruth Ann;
Suzuki, Takeaki;
Wages, David S.;
Wheeler, Catherine;
Richardson, Debra L.

Publication type:

Article

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.

Published in:

2022

By:

Sahai, Vaibhav;
Griffith, Kent A.;
Beg, Muhammad S.;
Shaib, Walid L.;
Mahalingam, Devalingam;
Zhen, David B.;
Deming, Dustin A.;
Zalupski, Mark M.

Publication type:

journal article

Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort.

Published in:

CardioVascular & Interventional Radiology, 2022, v. 45, n. 8, p. 1117, doi. 10.1007/s00270-022-03183-2

By:

Gupta, Aakash N.;
Gordon, Andrew C.;
Gabr, Ahmed;
Kalyan, Aparna;
Kircher, Sheetal M.;
Mahalingam, Devalingam;
Mulcahy, Mary F.;
Merkow, Ryan P.;
Yang, Anthony D.;
Bentrem, David J.;
Caicedo-Ramirez, Juan C.;
Riaz, Ahsun;
Thornburg, Bartley;
Desai, Kush;
Sato, Kent T.;
Hohlastos, Elias S.;
Kulik, Laura;
Benson, Al B.;
Salem, Riad;
Lewandowski, Robert J.

Publication type:

Article

Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.

Published in:

2020

By:

Ali, Rehan;
Yang, Yihe;
Antkowiak, Mark;
Gabr, Ahmed;
Mora, Ronald;
Abouchaleh, Nadine;
Asadi, Ali Al;
Kulik, Laura;
Ganger, Daniel;
Abecassis, Michael;
Katariya, Nitin;
Mulcahy, Mary;
Benson, Al;
Mahalingam, Devalingam;
Thornburg, Bartley;
Mouli, Samdeep;
Lewandowski, Robert J.;
Salem, Riad;
Riaz, Ahsun

Publication type:

corrected article

Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.

Published in:

CardioVascular & Interventional Radiology, 2019, v. 42, n. 5, p. 700, doi. 10.1007/s00270-019-02191-z

By:

Ali, Rehan;
Yang, Yihe;
Antkowiak, Mark;
Gabr, Ahmed;
Mora, Ronald;
Abouchaleh, Nadine;
Al Asadi, Ali;
Kulik, Laura;
Ganger, Daniel;
Abecassis, Michael;
Kataraya, Nitin;
Mulcahy, Mary;
Benson, Al;
Mahalingam, Devalingam;
Thornburg, Bartley;
Mouli, Samdeep;
Lewandowski, Robert J.;
Salem, Riad;
Riaz, Ahsun

Publication type:

Article

Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.

Published in:

2019

By:

Ali, Rehan;
Yang, Yihe;
Antkowiak, Mark;
Gabr, Ahmed;
Mora, Ronald;
Abouchaleh, Nadine;
Al Asadi, Ali;
Kulik, Laura;
Ganger, Daniel;
Abecassis, Michael;
Kataraya, Nitin;
Mulcahy, Mary;
Benson, Al;
Mahalingam, Devalingam;
Thornburg, Bartley;
Mouli, Samdeep;
Lewandowski, Robert J;
Salem, Riad;
Riaz, Ahsun

Publication type:

journal article

Advanced Cancer Patients' Understanding and Perceptions of Phase I Clinical Trials.

Published in:

2015

By:

Pawlowski, Jamie;
Malik, Laeeq;
Mahalingam, Devalingam

Publication type:

journal article

Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up.

Published in:

Oncologist, 2019, v. 24, n. 8, p. 1039, doi. 10.1634/theoncologist.2019-0330

By:

Rosenberg, Ari Joseph;
Rademaker, Alfred;
Hochster, Howard S.;
Ryan, Theresa;
Hensing, Thomas;
Shankaran, Veena;
Baddi, Lisa;
Mahalingam, Devalingam;
Mulcahy, Mary F.;
Benson, Al B.

Publication type:

Article

Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors.

Published in:

Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70724

By:

Chae, Young Kwang;
Duan, Richard;
Chung, Liam Il‐Young;
Oh, Youjin;
Alexiev, Borislav;
Shin, Sangwon;
Kim, Sukjun;
Helenowski, Irene;
Matsangou, Maria;
Villaflor, Victoria;
Mahalingam, Devalingam

Publication type:

Article

Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1836, doi. 10.1111/bcp.14289

By:

Mahalingam, Devalingam;
Patel, Manish R.;
Sachdev, Jasgit C.;
Hart, Lowell L.;
Halama, Niels;
Ramanathan, Ramesh K.;
Sarantopoulos, John;
Völkel, Dirk;
Youssef, Ashraf;
Jong, Floris A.;
Tsimberidou, Apostolia Maria

Publication type:

Article

Combined autophagy and HDAC inhibition.

Published in:

Autophagy, 2014, v. 10, n. 8, p. 1403, doi. 10.4161/auto.29231

By:

Mahalingam, Devalingam;
Mita, Monica;
Sarantopoulos, John;
Wood, Leslie;
Amaravadi, Ravi K.;
Davis, Lisa E.;
Mita, Alain C.;
Curiel, Tyler J.;
Espitia, Claudia M.;
Nawrocki, Steffan T.;
Giles, Francis J.;
Carew, Jennifer S.

Publication type:

Article

Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma.

Published in:

Journal of Surgical Oncology, 2023, v. 127, n. 1, p. 90, doi. 10.1002/jso.27112

By:

Silver, Casey M.;
Joung, Rachel H.;
Logan, Charles D.;
Benson, Al B.;
Mahalingam, Devalingam;
D'Angelica, Michael I.;
Bentrem, David J.;
Yang, Anthony D.;
Bilimoria, Karl Y.;
Merkow, Ryan P.

Publication type:

Article

Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC).

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 782, doi. 10.1038/s41416-023-02344-5

By:

Mahalingam, Devalingam;
Chen, Siqi;
Xie, Ping;
Loghmani, Houra;
Heineman, Thomas;
Kalyan, Aparna;
Kircher, Sheetal;
Helenowski, Irene B.;
Mi, Xinlei;
Maurer, Victoria;
Coffey, Matt;
Mulcahy, Mary;
Benson, Al-;
Zhang, Bin

Publication type:

Article

Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).

Published in:

2022

By:

Arora, Sukeshi Patel;
Tenner, Laura;
Sarantopoulos, John;
Morris, Jay;
Liu, Qianqian;
Mendez, Jenny A.;
Curiel, Tyler;
Michalek, Joel;
Mahalingam, Devalingam

Publication type:

journal article

Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2022, v. 40, n. 5, p. 1042, doi. 10.1007/s10637-022-01286-8

By:

Zhou, Xiaofei;
Vaishampayan, Ulka;
Mahalingam, Devalingam;
Harvey, R. Donald;
Chung, Ki Young;
Sedarati, Farhad;
Dong, Cassie;
Faller, Douglas V.;
Venkatakrishnan, Karthik;
Gupta, Neeraj

Publication type:

Article

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

Published in:

Investigational New Drugs, 2017, v. 35, n. 3, p. 386, doi. 10.1007/s10637-017-0425-4

By:

Fountzilas, Christos;
Stuart, Selena;
Hernandez, Brian;
Bowhay-Carnes, Elizabeth;
Michalek, Joel;
Sarantopoulos, John;
Karnad, Anand;
Patel, Sukeshi;
Weitman, Steven;
Mahalingam, Devalingam

Publication type:

Article

Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancer.

Published in:

Prostate, 2014, v. 74, n. 13, p. 1297, doi. 10.1002/pros.22846

By:

Osmulski, Pawel;
Mahalingam, Devalingam;
Gaczynska, Maria E.;
Liu, Joseph;
Huang, Susan;
Horning, Aaron M.;
Wang, Chiou‐Miin;
Thompson, Ian M.;
Huang, Tim H.‐M.;
Chen, Chun‐Liang

Publication type:

Article

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.

Published in:

Prostate, 2013, v. 73, n. 8, p. 813, doi. 10.1002/pros.22625

By:

Chen, Chun‐Liang;
Mahalingam, Devalingam;
Osmulski, Pawel;
Jadhav, Rohit R.;
Wang, Chiou‐Miin;
Leach, Robin J.;
Chang, Tien‐Cheng;
Weitman, Steven D.;
Kumar, Addanki Pratap;
Sun, LuZhe;
Gaczynska, Maria E.;
Thompson, Ian M.;
Huang, Tim Hui‐Ming

Publication type:

Article

Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.

Published in:

Nucleic Acids Research, 2016, v. 44, n. 9, p. 4105, doi. 10.1093/nar/gkv1528

By:

Sunkel, Benjamin;
Dayong Wu;
Zhong Chen;
Chiou-Miin Wang;
Xiangtao Liu;
Zhenqing Ye;
Horning, Aaron M.;
Liu, Joseph;
Mahalingam, Devalingam;
Lopez-Nicora, Horacio;
Chun-Lin Lin;
Goodfellow, Paul J.;
Clinton, Steven K.;
Jin, Victor X.;
Chun-Liang Chen;
Tim H.-M. Huang;
Qianben Wang

Publication type:

Article

Optimizing outcomes in patients with chronic myeloid leukemia in chronic phase: comparative safety profiles of newer agents.

Published in:

Leukemia & Lymphoma, 2010, v. 51, n. 8, p. 1399, doi. 10.3109/10428194.2010.491135

By:

Kelly, Kevin;
Swords, Ronan;
Mahalingam, Devalingam;
Giles, Francis J.

Publication type:

Article

Acute lymphoblastic leukemia presenting with avascular necrosis of the elbow.

Published in:

Leukemia & Lymphoma, 2009, v. 50, n. 2, p. 297, doi. 10.1080/10428190802607541

By:

Kelly, Kevin;
Swords, Ronan;
Kilcoyne, Aoife;
Sankhala, Kamalesh;
Mahalingam, Devalingam;
Padmanabhan, Swaminathan;
Giles, Francis

Publication type:

Article

Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial.

Published in:

2019

By:

Carneiro, Benedito A;
Konda, Bhavana;
Costa, Rubens B;
Costa, Ricardo L B;
Sagar, Vinay;
Gursel, Demirkan B;
Kirschner, Lawrence S;
Chae, Young Kwang;
Abdulkadir, Sarki A;
Rademaker, Alfred;
Mahalingam, Devalingam;
Shah, Manisha H;
Giles, Francis J

Publication type:

journal article